Document is current
Any future updates will be listed below
-
Authors
Kelly, William James
Giles, Amber Jin
Gilbert, Mark
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02658981 at ClinicalTrials.govnct03707457 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
nct02924038 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
For whom the T cells troll? Bispecific T-cell engagers in glioblastoma
https://doi.org/10.1136/jitc-2021-003679
Targeting Cbl-b in cancer immunotherapy
https://doi.org/10.1136/jitc-2022-006007
nct02335918 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
nct03688178 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)
https://doi.org/10.1136/esmoopen-2019-000629
Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors
https://doi.org/10.1136/jitc-2022-005147
nct03367715 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
nct02829931 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
nct03425292 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
nct03233152 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
Prospective phase I study of checkpoint blockade for the treatment of patients with newly diagnosed high-grade glioma prior to radiochemotherapy: Results of nivolumab plus ipilimumab treatment arm.
https://doi.org/10.1200/jco.2023.41.16_suppl.2057
nct03430791 at ClinicalTrials.govDocuments that mention this clinical trial
A phase I trial on the intra- and post-operative intracranial administration of ipilimumab and nivolumab in patients with recurrent high-grade glioma.
https://doi.org/10.1200/jco.2024.42.16_suppl.2037
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial
https://doi.org/10.1136/jitc-2020-002296
nct03422094 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
nct02794883 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
nct03491683 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
nct03347097 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
Shared epitopes create safety and efficacy concerns in several cancer vaccines
https://doi.org/10.1136/jitc-2025-012217
nct02359565 at ClinicalTrials.govDocuments that mention this clinical trial
Safety, efficacy, and biomarker analysis of response to engineered tumor-infiltrating lymphocytes secreting anti-PD-1 antibody in recurrent glioblastoma: An open-label, two-arms, phase 1 study.
https://doi.org/10.1200/jco.2023.41.16_suppl.2042
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
nct03173950 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
Trends in clinical development of pediatric cancer for PD-1 and PD-L1 inhibitors: an analysis of ClinicalTrials.gov
https://doi.org/10.1136/jitc-2021-002920
nct02311582 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
nct03341806 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
490 Laser interstitial thermal therapy plus pembrolizumab extends survival and ignites anti-tumor immunity in recurrent high-grade astrocytoma: results from a phase 1/randomized phase 2b trial
https://doi.org/10.1136/jitc-2025-sitc2025.0490
nct03493932 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
nct03119428 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019): part 1
https://doi.org/10.1186/s40425-019-0763-1
nct03961971 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
nct03018288 at ClinicalTrials.govDocuments that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
Lifting the innate immune barriers to antitumor immunity
https://doi.org/10.1136/jitc-2020-000695
nct03173950 at ClinicalTrials.govDocuments that mention this clinical trial
Advances in the management of glioblastoma
https://doi.org/10.1136/jnnp-2020-325334
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
Documents that mention this clinical trial
T lymphocyte-targeted immune checkpoint modulation in glioma
https://doi.org/10.1136/jitc-2019-000379
- License Information
